Kindstar Globalgene Technology, Inc. (HKG:9960)

Hong Kong · Delayed Price · Currency is HKD

1.210

-0.010 (-0.82%)

Jan 30, 2026, 4:08 PM HKT

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Hematology Testing	634.39M
Hematology Testing Growth	-2.74%
Neurology	103.38M
Neurology Growth	-3.15%
Maternity-related Diseases	58.42M
Maternity-related Diseases Growth	-4.60%
Genetic Diseases and Rare Diseases	48.52M
Genetic Diseases and Rare Diseases Growth	-6.01%
Scientific Research Services and Contract Research Organizations	48.42M
Scientific Research Services and Contract Research Organizations Growth	66.02%
Routine Testing	45.96M
Routine Testing Growth	-27.62%
Infectious Diseases	42.75M
Infectious Diseases Growth	-21.04%
Oncology	23.55M
Oncology Growth	-33.53%
Other	300.33K
Other Growth	-97.95%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	1.01B
China Growth	-5.91%